Latest return on equity
XTL Biopharmaceuticals Return on equity
XTL Biopharmaceuticals (XTLB) return on equity with its verified observation da…
Direct answer
XTL Biopharmaceuticals's return on equity is -29.3%.
The verified market snapshot reports -29.3%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 25, 2026.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -29.3%